White background.

PathOS™ Platform

pipeline

Dots arranged in a pattern, with several clusters of two or three dots each.

Pathos is redefining how drugs are developed, starting with Oncology.

The PathOS™ platform integrates advanced AI technology, biological modeling, and the largest collection of Multimodal patient data to increase the Probability of Success. By uniting these disciplines under one operating system, PathOS™ transforms data into insight — and insight into therapies that reach patients faster.

Black circle on a white background.
Black circle on a white background.
Black circle on white background.

To train the best AI models, you need the best data.


We have access to >200 petabytes of multimodal oncology data linked to patient outcomes.

This is 50x the size of The Cancer Genome Atlas (TCGA), the largest public genome dataset in oncology.

Black circle on a white background.
Black circle on a white background.
A black circle on a white background.

Pathos is transforming drug development through AI—integrating discovery, data, and clinical translation into one continuously learning system. With data and insight building impact, every stage of the process is connected, accelerated, and designed to reach patients faster.

Gray, horizontal gradient with a faint line near the center.

Pathos three Core Engines

Scout uses advanced AI to identify the drugs that are most likely to identify patients that don’t benefit from the current standard of care.

  • Scans the data for all investigational therapies
  • Matches each therapy to the patient subgroup most likely to respond
  • Produces a ranked list with the highest priority therapies

SCOUT

AI-Enabled Asset Selection Engine

Three digital figures, two blue, one gold, with a path leading to a glowing checkmark. Dark background.
Three digital figures, two blue, one gold, with a path leading to a glowing checkmark. Dark background.
Hand touching a glowing capsule, surrounded by digital particles, suggesting medical innovation.

SPRINT

AI-Enabled Clinical Execution Engine

Hand touching a glowing capsule, surrounded by digital particles, suggesting medical innovation.

Once Scout brings in an asset, it hands it off to a Sprint Pod, a small autonomous team that operates like an independent biotech company inside Pathos.

  • Sprint Pods utilize the Pathos platform to design clinical trials that won’t fail
  • AI Scientists and AI Engineers are core team members
  • Sprint Pods are focused on moving the asset from A to B (e.g. from Ph1 to Ph2, from Ph2 to Ph3 ready)

FOUNDRY

Pathos AI Platform. The Brain of the company.

Three figures composed of dots. Checkmarks on lines beside each figure, changing colors.

Foundry’s backbone is the Oncology Foundation Model we are building in partnership with Tempus and AstraZeneca — the largest model of its kind in the world


But Foundry is more than just a model. It leverages Pathos' wetlab to implement insight into the clinical validation lab-in-the-loop system.

Three figures composed of dots. Checkmarks on lines beside each figure, changing colors.

Together, these three engines power the next generation of drug development — one that discovers, innovates, advances precision therapies faster and with greater certainty for patients in need.

White background.
Right-pointing arrow.

Explore the therapies advancing through our AI-powered pipeline

Vertical, light blue stripes against a white background.